person

Yosr H.

Country
France
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
80
Sites with multiple studies

Has run more than one trial at 80 of 203 partner sites.

Specializations

Acute Myeloid Leukemia

This investigator specializes in treating acute myeloid leukemia, with particular emphasis on elderly patient populations. Their research encompasses post-remission therapy approaches and genomics-guided treatment strategies.

  • Elderly AML Management
  • Genomic Risk Stratification
  • Novel Therapeutic Combinations

Their work extends to evaluating deep remission outcomes and innovative treatment methodologies for various risk categories of AML.

Acute Lymphoblastic Leukemia

The investigator focuses on advancing treatment options for B-cell acute lymphoblastic leukemia and T-cell ALL. Their expertise includes managing both Philadelphia chromosome positive and negative variants of the disease.

  • Relapsed/Refractory B-ALL
  • Novel Immunotherapeutic Approaches
  • Stem Cell Transplantation Strategies

Their research encompasses frontline therapy optimization and innovative treatment approaches for diverse ALL subtypes.

Rare Blood Disorders

The investigator has expertise in treating paroxysmal nocturnal hemoglobinuria, focusing on complement inhibitor therapies and novel treatment approaches for this rare hematologic condition.

  • Complement Inhibition Therapy
  • PNH Management
  • Novel Therapeutic Evaluation

Their work includes assessment of treatment safety profiles and development of improved therapeutic strategies for PNH patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.